These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3406867)

  • 61. Systemic lupus erythematosus with anticardiolipin antibodies and lupus anticoagulant syndrome.
    Jawad AS; Berry H
    J R Soc Med; 1985 Aug; 78(8):677-8. PubMed ID: 4020804
    [No Abstract]   [Full Text] [Related]  

  • 62. Use of monoclonal antibodies to identify shared idiotypes on anticardiolipin and anti-DNA antibodies in human sera.
    Valesini G; Tincani A; Harris EN; Mantelli PG; Allegri F; Palmieri G; Hughes GR; Balsano F; Balestrieri G
    Clin Exp Immunol; 1987 Oct; 70(1):18-25. PubMed ID: 3500812
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus.
    Kuwana M; Kaburaki J; Okazaki Y; Miyazaki H; Ikeda Y
    Rheumatology (Oxford); 2006 Jul; 45(7):851-4. PubMed ID: 16418192
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Anticardiolipin antibody and complement.
    Cheng HM; Yap SF
    Arthritis Rheum; 1988 Sep; 31(9):1211-2. PubMed ID: 3422020
    [No Abstract]   [Full Text] [Related]  

  • 65. Systemic lupus erythematosus with complement deficiency and IgA anti-cardiolipin antibody.
    Markey AC; MacDonald DM
    Br J Dermatol; 1988 Nov; 119(5):633-7. PubMed ID: 3207615
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Association of antioxidized low-density lipoprotein antibodies with vascular arterial events and renal manifestations in systemic lupus erythematosus patients: comment on the article by Frostegård et al.
    Bertoli AM; Fernández M; McGwin G; Vilá LM; Reveille JD; Alarcón GS;
    Arthritis Rheum; 2006 Jun; 54(6):2035-6. PubMed ID: 16732576
    [No Abstract]   [Full Text] [Related]  

  • 67. Anticardiolipin antibodies: their relationship with HLA-DR antigens in systemic lupus erythematosus.
    Sebastiani GD; Lulli P; Passiu G; Trabace S; Bellucci AM; Morellini M; Galeazzi M
    Br J Rheumatol; 1991 Apr; 30(2):156-7. PubMed ID: 2012952
    [No Abstract]   [Full Text] [Related]  

  • 68. [Systemic lupus erythematosus. A new look].
    Derue G; Harris EN; Gharavi AE; Hughes GR
    Rev Rhum Mal Osteoartic; 1985 Feb; 52(2):69-71. PubMed ID: 3983562
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anticardiolipin antibodies in systemic lupus erythematous.
    Snowden N; Wilson P; Pumphrey R
    Ann Rheum Dis; 1989 Jan; 48(1):80-2. PubMed ID: 2923509
    [No Abstract]   [Full Text] [Related]  

  • 70. [Anti-phospholipid antibodies].
    Humbel R
    Bull Soc Sci Med Grand Duche Luxemb; 1987; 124(1):35-8. PubMed ID: 3664905
    [No Abstract]   [Full Text] [Related]  

  • 71. [Thrombocytopenia and thyroid disease. Possible relation to anti-phospholipid antibodies].
    Alarcón-Segovia D
    Rev Invest Clin; 1988; 40(1):113. PubMed ID: 3406556
    [No Abstract]   [Full Text] [Related]  

  • 72. Anticardiolipin and anti-beta 2-GPI are two distinct populations of autoantibodies.
    Sorice M; Circella A; Griggi T; Garofalo T; Nicodemo G; Pittoni V; Pontieri GM; Lenti L; Valesini G
    Thromb Haemost; 1996 Feb; 75(2):303-8. PubMed ID: 8815581
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The clinical utility of antihistone antibodies. Autoantibodies reactive with chromatin in systemic lupus erythematosus and drug-induced lupus.
    Burlingame RW
    Clin Lab Med; 1997 Sep; 17(3):367-78. PubMed ID: 9316764
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Occult anti-nuclear antibodies in thrombocytopenia preceding generalized lupus erythematosus].
    Vázquez-Escobosa C; Gómez-Estrada H; Romero-García F
    Rev Invest Clin; 1982; 34(3):229-33. PubMed ID: 6755597
    [No Abstract]   [Full Text] [Related]  

  • 75. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Negligible synergistic effect of beta2-glycoprotein I on the reactivity of antioxidized low-density lipoprotein antibody to oxidized low-density lipoprotein.
    Matsuda J; Gotoh M; Kawasugi K; Gohchi K; Tsukamoto M; Saitoh N
    Am J Hematol; 1996 Jun; 52(2):114-6. PubMed ID: 8638631
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Crossreactivity of antiphospholipid antibodies.
    Harris EN; Gharavi AE; Loizou S; Derue G; Chan JK; Patel BM; Mackworth-Young CG; Bunn CC; Hughes GR
    J Clin Lab Immunol; 1985 Jan; 16(1):1-6. PubMed ID: 3981615
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Thrombocytopenia, pregnancy and systemic lupus erythematosus].
    Gil A; Khamashta MA; Lavilla P; Vázquez JJ
    Med Clin (Barc); 1987 Jul; 89(6):259-60. PubMed ID: 3626692
    [No Abstract]   [Full Text] [Related]  

  • 79. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
    Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
    J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum.
    Sun KH; Liu WT; Tsai CY; Liao TS; Lin WM; Yu CL
    Ann Rheum Dis; 1992 Jun; 51(6):707-12. PubMed ID: 1616350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.